Case number 2018-1130
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | ALLERGAN, INC. v. TEVA PHARMACEUTICALS USA, INC. [RULE 36 JUDGMENT] [nonprecedential] (0) |
| Jun 3, 2019 | 116 | The petition for writ of certiorari, [18-1289], filed on 04/10/2019, was Denied on 06/03/2019. [611081] [JAB] [Entered: 06/03/2019 03:49 PM] (1) |
| Apr 10, 2019 | 115 | Petition for writ of Certiorari filed on 04/10/2019, and placed on the docket 04/10/2019, in the Supreme Court of the United States. Supreme Court #: 18-1289, Allergan, Inc., et al. v. Teva Pharmaceuticals USA, Inc. [599389] [JAB] [Entered: 04/11/2019 02:54 PM] (1) |
| Mar 13, 2019 | 114 | Mandate issued to the United States District Court for the Eastern District of Texas. Service as of this date by the Clerk of Court. [592403] [PBC] [Entered: 03/13/2019 08:59 AM] (2) |
| Mar 6, 2019 | 113 | ORDER filed denying [105] petition for panel rehearing filed by Allergan, Inc. and Saint Regis Mohawk Tribe; denying [105] petition for en banc rehearing filed by Allergan, Inc. and Saint Regis Mohawk Tribe. By: En Banc (Per Curiam). Service as of this date by the Clerk of Court. [590664] [PBC] [Entered: 03/06/2019 10:31 AM] (2) |
| Feb 19, 2019 | 112 | 20 paper copies of the response [111] received from Appellees Akorn, Inc., Mylan Pharmaceuticals Inc., Mylan, Inc. and Teva Pharmaceuticals USA, Inc. [586862] [PBC] [Entered: 02/19/2019 10:17 AM] (0) |
| Feb 14, 2019 | 111 | RESPONSE of Appellees Mylan Pharmaceuticals Inc., Mylan, Inc., Teva Pharmaceuticals USA, Inc. and Akorn, Inc. to the petition for panel rehearing [105] filed by Appellants Allergan, Inc. and Saint Regis Mohawk Tribe, petition for en banc rehearing [105] filed by Appellants Allergan, Inc. and Saint Regis Mohawk Tribe. Service: 02/14/2019 by email. [586187] [18-1130] [Wendy Devine] [Entered: 02/14/2019 06:53 PM] (32) |
| Jan 28, 2019 | 110 | ORDER filed granting motion to extend time to file response to rehearing/en banc [109] filed by Appellees Mylan Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., Akorn, Inc. and Mylan, Inc. By: Per Curiam. Service as of this date by the Clerk of Court. [581222] [JAB] [Entered: 01/28/2019 08:13 AM] (2) |
| Jan 23, 2019 | 109 | MOTION of Appellees Teva Pharmaceuticals USA, Inc., Mylan Pharmaceuticals Inc., Mylan, Inc. and Akorn, Inc. to extend the time to file a response to the Combined Petition for Panel Rehearing and Rehearing En Banc until 02/14/2019 [Consent: unopposed]. Service: 01/23/2019 by email. [580073] [18-1130] [John Rozendaal] [Entered: 01/23/2019 10:30 AM] (13) |
| Jan 17, 2019 | 108 | The court invites a combined response from Appellees Akorn, Inc., Mylan Pharmaceuticals Inc., Mylan, Inc. and Teva Pharmaceuticals USA, Inc. to the petition for panel rehearing, petition for en banc rehearing filed by Appellants in 18-1130. [578786] [JAB] [Entered: 01/17/2019 08:06 AM] (1) |
| Dec 26, 2018 | 107 | 18 paper copies of the petition for panel rehearing [105], petition for en banc rehearing [105] received from Appellants Allergan, Inc. and Saint Regis Mohawk Tribe. [574405] [JAB] [Entered: 12/26/2018 10:58 AM] (0) |
| Dec 21, 2018 | 103 | Petition for panel rehearing, for en banc rehearing filed by Appellants Allergan, Inc. and Saint Regis Mohawk Tribe. Service: 12/21/2018 by email. The paper copies of the petition must be filed within two business days (see Fed. Cir. R. 35(c)(4).The required paper copies should be received by the court on or before 12/27/2018 [574061] [18-1130] This petition has been corrected. See Doc. No. [105]. [Susan Morrison] [Entered: 12/21/2018 12:21 PM] (0) |
| Dec 21, 2018 | 104 | Petition for panel rehearing, for en banc rehearing filed by Appellants Allergan, Inc. and Saint Regis Mohawk Tribe. Service: 12/21/2018 by email. The paper copies of the petition must be filed within two business days (see Fed. Cir. R. 35(c)(4).The required paper copies should be received by the court on or before 12/27/2018 [574084] [18-1130] This petition has been corrected. See Doc. No. [105]. [Susan Morrison] [Entered: 12/21/2018 01:04 PM] (0) |
| Dec 21, 2018 | 105 | Petition for panel rehearing, for en banc rehearing filed by Appellants Allergan, Inc. and Saint Regis Mohawk Tribe. Service: 12/21/2018 by email. The paper copies of the petition must be filed within two business days (see Fed. Cir. R. 35(c)(4).The required paper copies should be received by the court on or before 12/27/2018 [574087] [18-1130] [Susan Morrison] [Entered: 12/21/2018 01:12 PM] (27) |
| Dec 21, 2018 | 106 | The party filed a corrected petition and is withdrawing [103] petition for panel rehearing, for en banc rehearing filed by Appellants Allergan, Inc. and Saint Regis Mohawk Tribe; withdrawing [104] petition for panel rehearing, for en banc rehearing filed by Appellants Allergan, Inc. and Saint Regis Mohawk Tribe. The previously filed petitions are withdrawn. [574103] [JAB] [Entered: 12/21/2018 01:41 PM] (0) |
| Dec 3, 2018 | 102 | ORDER filed granting motion to extend time to file petition for rehearing/en banc [101] filed by Appellants Allergan, Inc. and Saint Regis Mohawk Tribe. Petition for Rehearing due on or before 12/21/2018. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [569109] [JAB] [Entered: 12/03/2018 08:53 AM] (2) |
| Nov 29, 2018 | 101 | MOTION of Appellants Allergan, Inc. and Saint Regis Mohawk Tribe to extend the time to file a Combined Petition for Panel Rehearing and Rehearing En Banc until 12/21/2018 [Consent: unopposed]. Service: 11/29/2018 by email. [568677] [18-1130] [Susan Morrison] [Entered: 11/29/2018 03:44 PM] (11) |
| Nov 27, 2018 | 100 | Bill of Costs for Appellee Teva Pharmaceuticals USA, Inc.. Service: 11/27/2018 by email. Objection to Bill of Costs due on 12/11/2018. [567772] [18-1130] [John Rozendaal] [Entered: 11/27/2018 10:50 AM] (0) |
| Nov 13, 2018 | 99 | JUDGMENT filed. AFFIRMED. Issued pursuant to Federal Circuit Rule 36. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [564194] [PBC] [Entered: 11/13/2018 09:25 AM] (3) |
| Nov 6, 2018 | 98 | Submitted after ORAL ARGUMENT by Jonathan Elliot Singer for Allergan, Inc. and Saint Regis Mohawk Tribe and John Christopher Rozendaal for Teva Pharmaceuticals USA, Inc., Mylan Pharmaceuticals Inc., Mylan, Inc. and Akorn, Inc. Panel: Judge: Prost , Judge: Reyna , Judge: Hughes. [562891] [JAB] [Entered: 11/06/2018 11:15 AM] (0) |
| Oct 16, 2018 | 97 | CORRECTED Response to oral argument order from the Appellants Allergan, Inc. and Saint Regis Mohawk Tribe. Designating Jonathan E. Singer to argue.. Designating 12 minutes for argument. Reserving 3 minutes for rebuttal. [18-1130] [Jonathan Singer] [Entered: 10/16/2018 01:32 PM] (0) |
| Oct 15, 2018 | 93 | Response to oral argument order from the Appellant Allergan, Inc.. Designating Jonathan Singer to argue.. Designating 12 minutes for argument. Reserving 3 minutes for rebuttal. [18-1130] [Jonathan Singer] [Entered: 10/15/2018 11:57 AM] (0) |
| Oct 15, 2018 | 94 | Response to oral argument order from the Appellant Saint Regis Mohawk Tribe. Designating Michael W. Shore to argue.. Designating 0 minutes for argument. Reserving 0 minutes for rebuttal. [18-1130] [Michael Shore] [Entered: 10/15/2018 01:08 PM] (0) |
| Oct 15, 2018 | 95 | Response to oral argument order from the Appellees Teva Pharmaceuticals USA, Inc., Mylan Pharmaceuticals Inc., Mylan, Inc. and Akorn, Inc.. Designating John Christopher Rozendaal to argue.. Designating 15 minutes for argument. [18-1130] [John Rozendaal] [Entered: 10/15/2018 01:21 PM] (0) |
| Oct 15, 2018 | 96 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:calendar response Docket No. [94], ERROR: Counsel on behalf of Appellant Saint Regis Mohawk Tribe submitted a response to the oral argument order designating 0 minutes for argument and 0 minutes for rebuttal. CORRECTION: If the party wishes to waive argument, you must select the appropriate form of waiver from the drop-down menu when submitting the response. If one attorney is arguing on behalf of multiple parties, he/she must submit a response that indicates all parties represented at argument. Please promptly submit a corrected response. [557204] [JAB] [Entered: 10/15/2018 03:53 PM] (0) |
| Oct 9, 2018 | 92 | RESPONSE of Appellants Allergan, Inc. and Saint Regis Mohawk Tribe to the supplemental authority [91] filed by Appellees Teva Pharmaceuticals USA, Inc., Mylan Pharmaceuticals Inc., Mylan, Inc. and Akorn, Inc.. Service: 10/08/2018 by email. [555422] [18-1130] [Jonathan Singer] [Entered: 10/08/2018 09:19 PM] (2) |
| Sep 28, 2018 | 90 | RESPONSE of Appellees Teva Pharmaceuticals USA, Inc., Mylan Pharmaceuticals Inc., Mylan, Inc. and Akorn, Inc. to the supplemental authority [88] filed by Appellants Allergan, Inc. and Saint Regis Mohawk Tribe. Service: 09/28/2018 by email. [553387] [18-1130] [John Rozendaal] [Entered: 09/28/2018 03:52 PM] (3) |
| Sep 28, 2018 | 91 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellees Teva Pharmaceuticals USA, Inc., Mylan Pharmaceuticals Inc., Mylan, Inc. and Akorn, Inc.. Service: 09/28/2018 by email. [553389] [18-1130] [John Rozendaal] [Entered: 09/28/2018 03:54 PM] (33) |
| Sep 21, 2018 | 89 | NOTICE OF CALENDARING. Panel: 1811E. Case scheduled Nov 06, 2018 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 402. Response to oral argument order due: 10/15/2018. Arguing counsel must check-in with the Clerk's Office, 4th Floor, Room 401, between 8:30 a.m. and 9:30 a.m. on the day of argument. Please review the Oral Argument Order. [551742] [JAB] [Entered: 09/21/2018 02:43 PM] (0) |
| Sep 20, 2018 | 88 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellants Allergan, Inc. and Saint Regis Mohawk Tribe. Service: 09/20/2018 by email. [551428] [18-1130] [Jonathan Singer] [Entered: 09/20/2018 02:54 PM] (100) |
| Sep 6, 2018 | 87 | Notice from Appellee Teva Pharmaceuticals USA, Inc. regarding conflicts with oral argument (November 7-9, 2018). Service: 09/06/2018 by email. [547743] [18-1130] [John Rozendaal] [Entered: 09/06/2018 03:39 PM] (2) |
| Jul 13, 2018 | 83 | NOTICE OF DEFICIENCY: The party letter Document No. [82] filed by Appellant Allergan, Inc. in 18-1130 is submitted using the incorrect event and therefore cannot be accepted for filing at this time (Document must be submitted under the "Notice Regarding Conflicts with Argument Dates" event). You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [535595] [JAB] [Entered: 07/13/2018 08:12 AM] (0) |
| Jul 13, 2018 | 84 | Notice from Appellant Allergan, Inc. regarding conflicts with oral argument (September 4-5; October 1; November 5; December 3-7). Service: 07/13/2018 by email. [535669] [18-1130] [Jonathan Singer] [Entered: 07/13/2018 10:07 AM] (2) |
| Jul 13, 2018 | 85 | Notice from Appellee Teva Pharmaceuticals USA, Inc. regarding conflicts with oral argument (August 6-10, 2018). Service: 07/13/2018 by email. [535889] [18-1130] [John Rozendaal] [Entered: 07/13/2018 03:39 PM] (2) |
| Jul 13, 2018 | 86 | Notice from Appellees Mylan Pharmaceuticals Inc. and Mylan, Inc. regarding conflicts with oral argument (September 4-7, 2018). Service: 07/13/2018 by email. [535916] [18-1130] [Douglas Carsten] [Entered: 07/13/2018 04:55 PM] (2) |
| Jul 12, 2018 | 82 | Letter from Appellant Allergan, Inc. Conflict with Oral Argument dates. Service: 07/12/2018 by email. [535442] [18-1130] [Jonathan Singer] [Entered: 07/12/2018 12:27 PM] (2) |
| May 17, 2018 | 79 | MOTION of Appellee Akorn, Inc. to withdraw counsel Azadeh S. Kokabi [Consent: unopposed]. Service: 05/17/2018 by email. [522445] [18-1130] [Michael Dzwonczyk] [Entered: 05/17/2018 10:46 AM] (5) |
| May 17, 2018 | 80 | **TEXT ONLY** ORDER granting motion to withdraw attorney Azadeh S. Kokabi [79] filed by Appellee Akorn, Inc.. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [522593] [JB] [Entered: 05/17/2018 03:26 PM] (0) |
| May 17, 2018 | 81 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: The certificate of interest was not included with the motion to withdraw attorney and was not text searchable [79]. CORRECTION: Pursuant to FCR 27(a)(7), a certificate of interest must be included with each motion. As courtesy the case manager has replaced the document with a text searchable version. PLEASE NOTE: All documents submitted to the court must be text searchable.For future filings, please ensure the a certificate of interest is included and is text searchable. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [522598] [JB] [Entered: 05/17/2018 03:34 PM] (0) |
| May 10, 2018 | 78 | Entry of appearance for Christina Dashe as of counsel for Appellees Mylan Pharmaceuticals Inc. and Mylan, Inc.. Service: 05/10/2018 by email. [520842] [18-1130] [Christina Dashe] [Entered: 05/10/2018 04:55 PM] (2) |
| May 4, 2018 | 76 | **TEXT ONLY** ORDER granting motion to withdraw Anna G. Phillips [75] filed by Appellees Mylan Pharmaceuticals Inc. and Mylan, Inc. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [519166] [CFT] [Entered: 05/04/2018 11:10 AM] (0) |
| May 4, 2018 | 77 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: motion to withdraw attorney Docket No. [75], ERROR: Appellees' motion did not contain the required certificate of compliance with the word count. CORRECTION: Pursuant to FRAP 32(g)(1), motions must contain a certificate of compliance with the word count. Please ensure future motions include the certificate of compliance. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [519168] [CFT] [Entered: 05/04/2018 11:11 AM] (0) |
| May 3, 2018 | 74 | Amended Certificate of Interest for the Appellees Mylan Pharmaceuticals Inc. and Mylan, Inc.. Service: 05/03/2018 by email. [518792] [18-1130] [Douglas Carsten] [Entered: 05/03/2018 01:04 PM] (5) |
| May 3, 2018 | 75 | MOTION of Appellees Mylan Pharmaceuticals Inc. and Mylan, Inc. to withdraw counsel Anna G. Phillips [Consent: unopposed]. Service: 05/03/2018 by email. [518795] [18-1130] [Douglas Carsten] [Entered: 05/03/2018 01:07 PM] (7) |
| Apr 12, 2018 | 73 | Notice from Appellant Allergan, Inc. regarding conflicts with oral argument. Service: 04/12/2018 by email. [512848] [18-1130] [Jonathan Singer] [Entered: 04/12/2018 12:18 PM] (2) |
| Apr 11, 2018 | 70 | Letter from Appellee Akorn, Inc. Letter regarding no conflicts with Oral Arguments schedule. Service: 04/10/2018 by email. [512493] [18-1130] [Mark Boland] [Entered: 04/11/2018 02:30 PM] (2) |
| Apr 11, 2018 | 71 | Notice from Appellees Mylan Pharmaceuticals Inc. and Mylan, Inc. regarding conflicts with oral argument (June 4-8, 2018). Service: 04/11/2018 by email. [512664] [18-1130] [Douglas Carsten] [Entered: 04/11/2018 06:33 PM] (2) |
| Apr 11, 2018 | 72 | Notice from Appellee Teva Pharmaceuticals USA, Inc. regarding conflicts with oral argument (July 9-13 and August 6-10, 2018). Service: 04/11/2018 by email. [512678] [18-1130] [John Rozendaal] [Entered: 04/11/2018 08:17 PM] (2) |
| Apr 6, 2018 | 69 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks [JUN, JUL, AUG], or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 04/13/2018. [511387] [MJL] [Entered: 04/06/2018 02:43 PM] (0) |
| Apr 4, 2018 | 68 | 6 paper copies of the Joint Appendix in 2 Volumes [67] received from Appellants Allergan, Inc. and Saint Regis Mohawk Tribe. [511008] [SJL] [Entered: 04/05/2018 04:08 PM] (0) |
| Mar 27, 2018 | 64 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellant Allergan, Inc.. Service: 03/27/2018 by email. [508091] [18-1130] [Jonathan Singer] [Entered: 03/27/2018 08:37 AM] (2) |
| Mar 27, 2018 | 65 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellees Mylan Pharmaceuticals Inc. and Mylan, Inc.. Service: 03/27/2018 by email. [508222] [18-1130] [Douglas Carsten] [Entered: 03/27/2018 12:11 PM] (3) |
| Mar 27, 2018 | 66 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellee Akorn, Inc.. Service: 03/27/2018 by email. [508339] [18-1130] [Mark Boland] [Entered: 03/27/2018 03:11 PM] (3) |
| Mar 26, 2018 | 61 | TENDERED from Appellants Allergan, Inc. and Saint Regis Mohawk Tribe. Title: JOINT APPENDIX. Service: 03/26/2018 by email. [507784] [18-1130] [Jonathan Singer] [Entered: 03/26/2018 10:11 AM] (720) |
| Mar 26, 2018 | 67 | APPENDIX FILED for Allergan, Inc. and Saint Regis Mohawk Tribe [61]. Number of Pages: 720. Service: 03/26/2018 by email. The paper copies of the appendix should be received by the court on or before 04/06/2018. [509632] [MJL] [Entered: 03/30/2018 03:30 PM] (720) |
| Mar 26, 2018 | 62 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellants Allergan, Inc., Saint Regis Mohawk Tribe and Appellees Akorn, Inc., Mylan Pharmaceuticals Inc., Mylan, Inc. and Teva Pharmaceuticals USA, Inc.. Service: 03/26/2018 by email. [507933] [18-1130] [Jonathan Singer] [Entered: 03/26/2018 02:38 PM] (3) |
| Mar 26, 2018 | 63 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellee Teva Pharmaceuticals USA, Inc.. Service: 03/26/2018 by email. [508037] [18-1130] [John Rozendaal] [Entered: 03/26/2018 05:57 PM] (4) |
| Mar 23, 2018 | 60 | 6 paper copies of the Reply Brief [59] received from Appellants Allergan, Inc. and Saint Regis Mohawk Tribe. [507761] [SJL] [Entered: 03/26/2018 08:54 AM] (0) |
| Mar 19, 2018 | 58 | TENDERED from Appellants Allergan, Inc. and Saint Regis Mohawk Tribe. Title: REPLY BRIEF. Service: 03/19/2018 by email. [506334] [18-1130] [Jonathan Singer] [Entered: 03/19/2018 04:48 PM] (39) |
| Mar 19, 2018 | 59 | REPLY BRIEF FILED for Appellants Allergan, Inc. and Saint Regis Mohawk Tribe [58]. Number of Pages: 29. Service: 03/19/2018 by email. The paper copies of the brief should be received by the court on or before 03/27/2018. Appendix is due 03/26/2018. [506633] [FMS] [Entered: 03/20/2018 12:17 PM] (39) |
| Mar 9, 2018 | 57 | 6 paper copies of the Opening Response Brief [56] received from Appellees Akorn, Inc., Mylan Pharmaceuticals Inc., Mylan, Inc. and Teva Pharmaceuticals USA, Inc. [503726] [JCP] [Entered: 03/09/2018 10:24 AM] (0) |
| Mar 5, 2018 | 55 | TENDERED from Appellees Akorn, Inc., Mylan Pharmaceuticals Inc., Mylan, Inc. and Teva Pharmaceuticals USA, Inc.. Title: RESPONSE BRIEF. Service: 03/05/2018 by email. [502725] [John Rozendaal] [Entered: 03/05/2018 08:54 PM] (82) |
| Mar 5, 2018 | 56 | BRIEF FILED for Appellees Akorn, Inc., Mylan Pharmaceuticals Inc., Mylan, Inc. and Teva Pharmaceuticals USA, Inc. [55]. Number of Pages: 62. Service: 03/05/2018 by email. The paper copies of the brief should be received by the court on or before 03/14/2018. Appellants Allergan, Inc. and Saint Regis Mohawk Tribe reply brief is due 03/19/2018. [503303] [CMP] [Entered: 03/07/2018 03:42 PM] (82) |
| Feb 14, 2018 | 54 | **TEXT ONLY** ORDER granting motion to extend time to file appellee's principal brief [53] filed by Appellees Mylan Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., Akorn, Inc. and Mylan, Inc. Appellees Akorn, Inc., Mylan Pharmaceuticals Inc., Mylan, Inc. and Teva Pharmaceuticals USA, Inc. brief is due 03/05/2018. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [497630] [FMS] [Entered: 02/14/2018 12:22 PM] (0) |
| Feb 12, 2018 | 53 | MOTION of Appellees Akorn, Inc., Mylan Pharmaceuticals Inc., Mylan, Inc. and Teva Pharmaceuticals USA, Inc. to extend the time to 03/05/2018 to file the appellee/respondent/cross-appellant's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 02/12/2018 by email. [497168] [Douglas Carsten] [Entered: 02/12/2018 05:56 PM] (14) |
| Feb 5, 2018 | 52 | 6 paper copies of the Amicus Brief [49] received from Amicus Curiae Pharmaceutical Research and Manufacturers of America. [495409] [CFT] [Entered: 02/06/2018 09:26 AM] (0) |
| Feb 1, 2018 | 51 | Entry of appearance for Benjamin Cappel as of counsel for Appellee Akorn, Inc.. Service: 02/01/2018 by email, clerk. [494386] [Mark Boland] [Entered: 02/01/2018 12:31 PM] (2) |
| Jan 31, 2018 | 48 | ORDER filed. The motion [45] is granted. (Per Curiam). Service: 01/31/2018 by clerk. [494011] [LMS] [Entered: 01/31/2018 11:50 AM] (2) |
| Jan 31, 2018 | 49 | AMICUS BRIEF FILED for Pharmaceutical Research and Manufacturers of America [46]. Number of Pages: 13. Service: 01/16/2018 by email. The paper copies of the brief should be received by the court on or before 02/07/2018. [494048] [FMS] [Entered: 01/31/2018 01:09 PM] (21) |
| Jan 31, 2018 | 50 | Certificate of Interest for the Amicus Curiae Pharmaceutical Research and Manufacturers of America. Service: 01/31/2018 by email. [494136] [Aaron Stiefel] [Entered: 01/31/2018 03:11 PM] (4) |
| Jan 18, 2018 | 47 | 6 paper copies of the Opening Brief [42] received from Appellants Allergan, Inc. and Saint Regis Mohawk Tribe. [490669] [CFT] [Entered: 01/18/2018 12:15 PM] (0) |
| Jan 16, 2018 | 43 | Entry of appearance for David Korn as of counsel for Pharmaceutical Research and Manufacturers of America. Service: 01/16/2018 by email. [489985] [David Korn] [Entered: 01/16/2018 05:26 PM] (2) |
| Jan 16, 2018 | 44 | Entry of appearance for Aaron Stiefel as principal counsel for Pharmaceutical Research and Manufacturers of America. Service: 01/16/2018 by email. [490009] [Aaron Stiefel] [Entered: 01/16/2018 05:48 PM] (2) |
| Jan 16, 2018 | 45 | MOTION of Pharmaceutical Research and Manufacturers of America for leave to file an amicus curiae brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 01/16/2018 by email. [490015] [Aaron Stiefel] [Entered: 01/16/2018 05:56 PM] (8) |
| Jan 16, 2018 | 46 | TENDERED from Pharmaceutical Research and Manufacturers of America Title: AMICUS CURIAE BRIEF. Service: 01/16/2018 by email. [490020] [Aaron Stiefel] [Entered: 01/16/2018 06:04 PM] (21) |
| Jan 9, 2018 | 41 | TENDERED from Appellants Allergan, Inc. and Saint Regis Mohawk Tribe. Title: OPENING BRIEF. Service: 01/09/2018 by email. [488513] [Jonathan Singer] [Entered: 01/09/2018 07:29 PM] (263) |
| Jan 9, 2018 | 42 | BRIEF FILED for Appellants Allergan, Inc. and Saint Regis Mohawk Tribe [41]. Number of Pages: 61. Service: 01/09/2018 by email. The paper copies of the brief should be received by the court on or before 01/18/2018. Appellees Akorn, Inc., Mylan Pharmaceuticals Inc., Mylan, Inc. and Teva Pharmaceuticals USA, Inc. brief is due 02/20/2018. [488685] [FMS] [Entered: 01/10/2018 01:29 PM] (263) |
| Jan 3, 2018 | 40 | ORDER filed. The motion [34] is denied. Service: 01/03/2018 by clerk. [487115] [LMS] [Entered: 01/03/2018 02:55 PM] (2) |
| Dec 22, 2017 | 39 | **TEXT ONLY** ORDER granting motion to extend time to file appellant's principal brief [38] filed by Appellants Allergan, Inc. and Saint Regis Mohawk Tribe. The brief is due 01/09/2018. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [485102] [FMS] [Entered: 12/22/2017 08:54 AM] (0) |
| Dec 21, 2017 | 38 | MOTION of Appellants Allergan, Inc. and Saint Regis Mohawk Tribe to extend the time to 01/09/2018 to file the appellant/petitioner's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 12/21/2017 by email. [484852] [Deanna Reichel] [Entered: 12/21/2017 02:35 PM] (9) |
| Dec 18, 2017 | 36 | REPLY of Appellants Allergan, Inc. and Saint Regis Mohawk Tribe to response filed by Appellees in 18-1130 , Doc. No [35]. Service: 12/18/2017 by email. [483496] [Susan Morrison] [Entered: 12/18/2017 05:47 PM] (81) |
| Dec 18, 2017 | 37 | Amended Certificate of Interest for the Appellee Teva Pharmaceuticals USA, Inc.. Service: 12/18/2017 by email. [483513] [John Rozendaal] [Entered: 12/18/2017 07:57 PM] (3) |
| Dec 11, 2017 | 35 | RESPONSE of Appellees Akorn, Inc., Mylan Pharmaceuticals Inc., Mylan, Inc. and Teva Pharmaceuticals USA, Inc. to the motion for other relief [34] filed by Appellants Allergan, Inc. and Saint Regis Mohawk Tribe in 18-1130. Service: 12/11/2017 by email. [481802] [Douglas Carsten] [Entered: 12/11/2017 07:05 PM] (286) |
| Dec 1, 2017 | 34 | MOTION of Appellants Allergan, Inc. and Saint Regis Mohawk Tribe for production of FDA correspondence and notice of FDA Approval. Any response is due within 10 days of service [Consent: opposed]. Service: 12/01/2017 by email. [479739] [Susan Morrison] [Entered: 12/01/2017 05:28 PM] (37) |
| Nov 15, 2017 | 2 | Entry of appearance for Jonathan E. Singer as principal counsel for Appellant Allergan, Inc.. Service: 11/15/2017 by email. [475619] [Jonathan Singer] [Entered: 11/15/2017 09:21 AM] (2) |
| Nov 15, 2017 | 3 | Entry of appearance for Deanna J. Reichel as of counsel for Appellant Allergan, Inc.. Service: 11/15/2017 by email. [475624] [Deanna Reichel] [Entered: 11/15/2017 09:26 AM] (2) |
| Nov 15, 2017 | 4 | Entry of appearance for Susan E. Morrison as of counsel for Appellant Allergan, Inc.. Service: 11/15/2017 by email. [475660] [Susan Morrison] [Entered: 11/15/2017 10:42 AM] (2) |
| Nov 15, 2017 | 5 | Entry of appearance for Robert M. Oakes as of counsel for Appellant Allergan, Inc.. Service: 11/15/2017 by email. [475661] [Robert Oakes] [Entered: 11/15/2017 10:44 AM] (2) |
| Nov 15, 2017 | 6 | Entry of appearance for Joseph Herriges as of counsel for Appellant Allergan, Inc.. Service: 11/15/2017 by email. [475662] [Joseph Herriges] [Entered: 11/15/2017 10:47 AM] (2) |
| Nov 15, 2017 | 7 | Entry of appearance for Juanita R. Brooks as of counsel for Appellant Allergan, Inc.. Service: 11/15/2017 by email. [475665] [Juanita Brooks] [Entered: 11/15/2017 10:49 AM] (2) |
| Nov 15, 2017 | 8 | Certificate of Interest for the Appellant Allergan, Inc.. Service: 11/15/2017 by email. [475670] [Jonathan Singer] [Entered: 11/15/2017 10:54 AM] (3) |
| Nov 15, 2017 | 9 | Docketing Statement for the Appellant Allergan, Inc.. Service: 11/15/2017 by email. [475671] [Jonathan Singer] [Entered: 11/15/2017 10:55 AM] (3) |
| Nov 15, 2017 | 10 | Entry of appearance for Michael W. Shore as principal counsel for Appellant Saint Regis Mohawk Tribe. Service: 11/15/2017 by email. [475754] [Michael Shore] [Entered: 11/15/2017 12:29 PM] (2) |
| Nov 15, 2017 | 11 | Entry of appearance for Christopher L. Evans as of counsel for Appellant Saint Regis Mohawk Tribe. Service: 11/15/2017 by email. [475760] [Christopher Evans] [Entered: 11/15/2017 12:33 PM] (2) |
| Nov 15, 2017 | 12 | Entry of appearance for Russell J. DePalma as of counsel for Appellant Saint Regis Mohawk Tribe. Service: 11/15/2017 by email. [475761] [Russell DePalma] [Entered: 11/15/2017 12:34 PM] (2) |
| Nov 15, 2017 | 13 | Certificate of Interest for the Appellant Saint Regis Mohawk Tribe. Service: 11/15/2017 by email. [475766] [Michael Shore] [Entered: 11/15/2017 12:43 PM] (3) |
| Nov 15, 2017 | 14 | Docketing Statement for the Appellant Saint Regis Mohawk Tribe. Service: 11/15/2017 by email. [475767] [Michael Shore] [Entered: 11/15/2017 12:43 PM] (3) |
| Nov 15, 2017 | 15 | Entry of appearance for Michael Dzwonczyk as principal counsel for Appellee Akorn, Inc.. Service: 11/15/2017 by email, clerk. [475867] [Mark Boland] [Entered: 11/15/2017 03:06 PM] (2) |
| Nov 15, 2017 | 16 | Entry of appearance for Mark Boland as of counsel for Appellee Akorn, Inc.. Service: 11/15/2017 by email, clerk. [475871] [Mark Boland] [Entered: 11/15/2017 03:08 PM] (2) |
| Nov 15, 2017 | 17 | Entry of appearance for Azadeh S. Kokabi as of counsel for Appellee Akorn, Inc.. Service: 11/15/2017 by email, clerk. [475874] [Mark Boland] [Entered: 11/15/2017 03:09 PM] (2) |
| Nov 15, 2017 | 18 | Certificate of Interest for the Appellee Akorn, Inc.. Service: 11/15/2017 by email, clerk. [475875] [Mark Boland] [Entered: 11/15/2017 03:10 PM] (0) |
| Nov 15, 2017 | 19 | Docketing Statement for the Appellee Akorn, Inc.. Service: 11/15/2017 by email, clerk. [475878] [Mark Boland] [Entered: 11/15/2017 03:11 PM] (4) |
| Nov 15, 2017 | 20 | NOTICE OF DEFICIENCY: The certificate of interest Document No. [18] filed by Appellee Akorn, Inc. in 18-1130 is incomplete [QUESTION #3] and therefore cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [475906] [FMS] [Entered: 11/15/2017 03:44 PM] (0) |
| Nov 15, 2017 | 21 | Amended Certificate of Interest for the Appellee Akorn, Inc.. Service: 11/15/2017 by email, clerk. [475913] [Mark Boland] [Entered: 11/15/2017 03:55 PM] (3) |
| Nov 15, 2017 | 22 | Entry of appearance for John Christopher Rozendaal as principal counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 11/15/2017 by email. [475945] [John Rozendaal] [Entered: 11/15/2017 04:53 PM] (2) |
| Nov 15, 2017 | 23 | Entry of appearance for Michael E. Joffre as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 11/15/2017 by email. [475946] [Michael Joffre] [Entered: 11/15/2017 04:55 PM] (2) |
| Nov 15, 2017 | 24 | Entry of appearance for Pauline Pelletier as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 11/15/2017 by email. [475947] [Pauline Pelletier] [Entered: 11/15/2017 04:57 PM] (2) |
| Nov 15, 2017 | 25 | Entry of appearance for Ralph Wilson Powers III as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 11/15/2017 by email. [475948] [Ralph Powers] [Entered: 11/15/2017 04:59 PM] (2) |
| Nov 15, 2017 | 26 | Entry of appearance for William H. Milliken as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 11/15/2017 by email. [475950] [William Milliken] [Entered: 11/15/2017 05:02 PM] (2) |
| Nov 15, 2017 | 27 | Certificate of Interest for the Appellee Teva Pharmaceuticals USA, Inc.. Service: 11/15/2017 by email. [475953] [John Rozendaal] [Entered: 11/15/2017 05:04 PM] (3) |
| Nov 15, 2017 | 28 | Docketing Statement for the Appellee Teva Pharmaceuticals USA, Inc.. Service: 11/15/2017 by email. [475955] [John Rozendaal] [Entered: 11/15/2017 05:05 PM] (4) |
| Nov 15, 2017 | 29 | Entry of appearance for Douglas H. Carsten as principal counsel for Appellees Mylan Pharmaceuticals Inc. and Mylan, Inc.. Service: 11/15/2017 by email. [475964] [Douglas Carsten] [Entered: 11/15/2017 05:37 PM] (2) |
| Nov 15, 2017 | 30 | Entry of appearance for Wendy L. Devine as of counsel for Appellees Mylan Pharmaceuticals Inc. and Mylan, Inc.. Service: 11/15/2017 by email. [475967] [Wendy Devine] [Entered: 11/15/2017 05:41 PM] (2) |
| Nov 15, 2017 | 31 | Entry of appearance for Anna Phillips as of counsel for Appellees Mylan Pharmaceuticals Inc. and Mylan, Inc.. Service: 11/15/2017 by email. [475972] [Anna Phillips] [Entered: 11/15/2017 05:53 PM] (2) |
| Nov 15, 2017 | 32 | Docketing Statement for the Appellees Mylan Pharmaceuticals Inc. and Mylan, Inc.. Service: 11/15/2017 by email. [475973] [Douglas Carsten] [Entered: 11/15/2017 05:57 PM] (4) |
| Nov 15, 2017 | 33 | Certificate of Interest for the Appellees Mylan Pharmaceuticals Inc. and Mylan, Inc.. Service: 11/15/2017 by email. [475974] [Douglas Carsten] [Entered: 11/15/2017 06:00 PM] (5) |
| Nov 1, 2017 | 1 | Appeal docketed. Received: 10/30/2017. [472248]Entry of Appearance due 11/15/2017. Certificate of Interest is due on 11/15/2017. Docketing Statement due 11/15/2017. Appellant/Petitioner's brief is due 01/02/2018. [FMS] [Entered: 11/01/2017 12:42 PM] (211) |
